Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

SUREFIRE RESOURCES NL Director's Dealing 2006

Dec 11, 2006

65857_rns_2006-12-11_03cab8c3-7bde-4e3e-a4fb-399174139e5f.pdf

Director's Dealing

Open in viewer

Opens in your device viewer

Appendix 3Y

Rule 3.19A.2

Change of Director's Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX's property and may be made public.

Introduced 30/9/2001.

Name of entity: Genesis Biomedical Limited
ABN: 48 083 274 024

We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.

Name of Director Mr Donald Lawrence Valentino
Date of last notice 30 May 2006

Part 1 - Change of director's relevant interests in securities

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of "notifiable interest of a director" should be disclosed in this part.

Direct or indirect interest Transfer of control to Donald Lawrence
Valentino
Nature of indirect interest Transfer of control of:
(including registered holder)
Note: Provide details of the circumstances giving rise to the relevantinterest. 1,820,000 Fully Paid Ordinary Shares
900,000 Options $0.03, 30 November 2010
From: Paul Matthew Valentino
David Peter Valentino
To: Mr Donald Lawrence Valentino
Date of change of control 7 December 2006
No. of securities held prior to change 4,798,267 Fully Paid Ordinary Shares
4,498,267 Options $0.03, 30 November 2010
Class Ordinary Shares
Options $0.03, 30 November 2010
Number of securities for which control has been 1,820,000 Fully Paid Ordinary Shares
transferred 900,000 Options $0.03, 30 November 2010
Number disposed Nil
Value/Consideration Nil, no change of registered holder
Note: If consideration is non-cash, provide details and estimated valuation

+ See chapter 19 for defined terms.

No. of securities controlled after change 6,618,267 Fully Paid Ordinary Shares5.398,267 Options $0.03, 30 November 2010
Nature of changeExample: on-market trade, off-market trade, exercise of options, issue ofsecurities under dividend reinvestment plan, participation in buy-back- Change of control of additional securities

Part 2 - Change of director's interests in contracts

Note: In the case of a company, interests which come within paragraph (ii) of the definition of "notifiable interest of a director" should be disclosed in this part.

Detail of contract Nil
Nature of interest
Name of registered holder(if issued securities)
Date of change
No. and class of securities towhich interest related prior tochangeNote: Details are only required for a contract in relationto which the interest has changed
Interest acquired
Interest disposed
Value/ConsiderationNote: If consideration is non-cash, provide details and anestimated valuation
Interest after change

$\div$ See chapter 19 for defined terms.